scholarly journals Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology ◽  
2016 ◽  
Vol 58 ◽  
pp. 41-48 ◽  
Author(s):  
Loren Michel ◽  
Jessica Ley ◽  
Tanya M. Wildes ◽  
András Schaffer ◽  
Anthony Robinson ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Trial ◽  
Neck Squamous Cell Carcinoma ◽  
Cyclin Dependent Kinase

Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial

2020 ◽  
Vol 142 ◽  
pp. 79-84 ◽  
Author(s):  
Joris B.W. Elbers ◽  
Abrahim Al-Mamgani ◽  
Margot E.T. Tesseslaar ◽  
Michiel W.M. van den Brekel ◽  
Charlotte A.H. Lange ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Trial ◽  
Neck Squamous Cell Carcinoma ◽  
Advanced Stage

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

Oral Oncology ◽  
2008 ◽  
Vol 44 (9) ◽  
pp. 823-829 ◽  
Author(s):  
Herbert Riechelmann ◽  
Alexander Sauter ◽  
Wolfram Golze ◽  
Gertraud Hanft ◽  
Carsten Schroen ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Trial ◽  
Neck Squamous Cell Carcinoma

scholarly journals Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

2013 ◽  
Vol 8 (1) ◽  
pp. 40 ◽  
Author(s):  
Yungan Tao ◽  
Etienne Bardet ◽  
Dominique Rosine ◽  
Frédéric Rolland ◽  
Emmanuelle Bompas ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase I Trial ◽  
Neck Squamous Cell Carcinoma ◽  
Oral Etoposide
Sign in / Sign up

Export Citation Format

Share Document